You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nucleoside/Nucleotide Analogue

Showing 1 - 25 of 2,525
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Steatohepatitis in Chronic Hepatitis B

Completed
  • Fatty Liver
  • Chronic Hepatitis b
  • Antiviral Agents
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital
Mar 30, 2022

Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • HRS9950 tablets
  • HRS9950 placebo tablets
  • (no location specified)
Jun 7, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Advanced Cancer, Lymphoma, Solid Tumor Trial in Edinburgh, Newcastle, Oxford (NUC-7738)

Recruiting
  • Advanced Cancer
  • +2 more
  • Edinburgh, United Kingdom
  • +2 more
Dec 7, 2022

Hepatitis B, HBV, Hepatitis B, Chronic Trial in Canada, United Kingdom (Inarigivir soproxil, Nucleoside/nucleotide (NUC)

Terminated
  • Hepatitis B
  • +2 more
  • Inarigivir soproxil
  • Nucleoside/nucleotide (NUC) analogue inhibitors
  • Calgary, Alberta, Canada
  • +6 more
Jul 20, 2020

HIV-1 Infection Trial in France (Samplings)

Recruiting
  • HIV-1 Infection
  • Samplings
  • Clamart, France
  • +6 more
Jan 4, 2022

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

Active, not recruiting
  • Hepatitis B, Chronic
  • Stop of therapy
  • København, Denmark
  • +10 more
Sep 13, 2021

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

HCC, HBV Coinfection Trial in Chengdu (Tenofovir Disoproxil, Entecavir)

Active, not recruiting
  • HCC
  • HBV Coinfection
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
May 23, 2022

PET Imaging of the Immune System Using Analog Probes

Completed
  • Malignant Melanoma
  • [18F] CFA
  • Los Angeles, California
    University of California, Los Angeles
Oct 8, 2021

Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

Recruiting
  • Chronic HBV Infection
  • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
  • +2 more
  • Beijing, Beijing, China
  • +7 more
Feb 23, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Stopping Antiviral Treatment in Chronic Hepatitis B

    Recruiting
    • Chronic Hepatitis b
    • Hong Kong, Please Select One ..., Hong Kong
      Man Fung Yuen
    Sep 28, 2021

    Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,

    Recruiting
    • Colorectal Cancer
    • +4 more
    • Fosifloxuridine Nafalbenamide
    • +4 more
    • Wichita, Kansas
    • +5 more
    Jan 9, 2023

    Real-world Study Optimizing Nucleotide-analogues

    Recruiting
    • Hepatitis B, Chronic
    • Hefei, Anhui, China
    • +43 more
    Jul 7, 2023

    Chronic Hepatitis b, Hepatitis B Reactivation Trial in Taiwan (Vemlidy)

    Recruiting
    • Chronic Hepatitis b
    • Hepatitis B Reactivation
    • Chiayi City, Taiwan
    • +6 more
    Aug 4, 2021

    HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +22 more
    Oct 28, 2021

    Treatment Optimization of Refractory

    Recruiting
    • Hepatitis B, Chronic
    • Virus Diseases
    • original therapy
    • rescue therapy
    • Ankang, China
    • +12 more
    Feb 1, 2023

    HIV Trial in Worldwide (Darunavir (DRV) 800 milligram (MG) Oral Tablet, Ritonavir 100 MG Oral Tablet, N(t)RTIs)

    Recruiting
    • HIV Infections
    • Darunavir (DRV) 800 milligram (MG) Oral Tablet
    • +6 more
    • Chennai, India
    • +6 more
    Aug 30, 2021

    Chronic Hepatitis b Trial in Guangzhou (Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide)

    Recruiting
    • Chronic Hepatitis b
    • Guangzhou, Guangdong, China
      Third Affiliated Hospital of Sun Yat-sen University
    Dec 15, 2019

    Chronic Hepatitis b Trial in Chongqing, Xi'an (Placebo, TQA3605 tablets, Entecavir dispersible tablets)

    Recruiting
    • Chronic Hepatitis b
    • Placebo
    • +4 more
    • Chongqing, Chongqing, China
    • +2 more
    Nov 27, 2023

    HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

    Not yet recruiting
    • HBV
    • HCC
    • nucleoside analogues or interferon
    • Hefei, Anhui, China
    • +9 more
    Jul 20, 2023

    Parathyroid Hormone, Tenofovir Disoproxil Fumarate, Chronic Hepatitis, B Virus Without Hepatitis Delta (Diagnosis) Trial in

    Not yet recruiting
    • Parathyroid Hormone
    • +3 more
    • Ergocalciferol Capsules
    • Calcium carbonate
    • Bangkok Noi, Bangkok, Thailand
      Faculty of Medicine Siriraj Hospital, Mahidol University
    Mar 28, 2022

    HIV-infection/Aids, Human Herpesvirus 4 Infections, Cytomegalovirus Infections Trial (NRTIs, Darunavir, Ritonavir)

    Withdrawn
    • HIV-infection/Aids
    • +4 more
    • (no location specified)
    Nov 8, 2020